United States · FDA National Drug Code directory
Nayzilam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50474-500_5776d86f-c632-429f-ac0b-88ade1a3930c
- Product NDC
- 50474-500
- Form
- SPRAY
- Composition / generic term
- midazolam
- Labeler
- UCB, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190517
- Source listing expiry
- 20261231
Source-listed ingredients
- MIDAZOLAM — 5 mg/.1mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BLISTER PACK in 1 CARTON (50474-500-15) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK (50474-500-14) / .1 mL in 1 VIAL, SINGLE-DOSE · 50474-500-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →